Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.69B |
| 2 |
SPYM
State Street SPDR Portfolio S&P 500 ETF
SPYM
|
+$1.32B |
| 3 |
Vanguard Total Bond Market
BND
|
+$1.21B |
| 4 |
SPDR Gold Trust
GLD
|
+$970M |
| 5 |
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
|
+$842M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$7.66B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$5.23B |
| 3 |
Accenture
ACN
|
+$1.14B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.13B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$635M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.44% |
| 2 | Financials | 11.15% |
| 3 | Consumer Discretionary | 8.06% |
| 4 | Healthcare | 8.02% |
| 5 | Communication Services | 7.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2926
State Street SPDR S&P Health Care Equipment ETF
XHE
$161M
| $20.1M | ﹤0.01% |
227,403
+123,248
| +118% | +$10.4M |
|
2927
Cohu
COHU
$2B
| $20M | ﹤0.01% |
860,196
+164,837
| +24% | +$3.78M |
|
2928
Innodata
INOD
$1.88B
| $20M | ﹤0.01% |
392,800
-721,993
| -65% | -$47.1M |
|
2929
Dimensional US Core Equity 2 ETF
DFAC
$47.7B
| $20M | ﹤0.01% |
505,370
-28,533
| -5% | -$1.11M |
|
2930
Preferred Bank
PFBC
$1.25B
| $20M | ﹤0.01% |
211,840
-28,064
| -12% | -$2.62M |
|
2931
Fidelity MSCI Utilities Index ETF
FUTY
$2.37B
| $20M | ﹤0.01% |
361,941
+14,221
| +4% | +$814K |
|
2932
International Bancshares
IBOC
$4.83B
| $20M | ﹤0.01% |
300,642
+50,688
| +20% | +$3.43M |
|
2933
Nuveen Dynamic Municipal Opportunities Fund
NDMO
$607M
| $20M | ﹤0.01% |
1,981,391
+245,072
| +14% | +$2.56M |
|
2934
MidCap Financial Investment
MFIC
$811M
| $19.9M | ﹤0.01% |
1,743,681
-173,153
| -9% | -$2.05M |
|
|
JMIA
2935
Jumia Technologies
JMIA
$741M
| $19.9M | ﹤0.01% |
1,595,217
+671,270
| +73% | +$7.76M |
|
2936
OrthoPediatrics
KIDS
$510M
| $19.8M | ﹤0.01% |
1,116,141
+4,693
| +0.4% | +$82.2K |
|
|
FTF
2937
Franklin Limited Duration Income Trust
FTF
$233M
| $19.8M | ﹤0.01% |
3,218,111
+213,003
| +7% | +$1.31M |
|
2938
NCR Voyix
VYX
$1.19B
| $19.8M | ﹤0.01% |
1,938,547
+314,277
| +19% | +$3.41M |
|
2939
ProKidney
PROK
$316M
| $19.8M | ﹤0.01% |
8,817,001
+2,069,979
| +31% | +$5.44M |
|
2940
FlexShares High Yield Value-Scored Bond Index Fund
HYGV
$1.09B
| $19.7M | ﹤0.01% |
484,214
+28,277
| +6% | +$1.15M |
|
2941
AtaiBeckley Inc
ATAI
$2.66B
| $19.7M | ﹤0.01% |
4,820,973
+5,410
| +0.1% | +$25.5K |
|
2942
Perella Weinberg Partners
PWP
$1.18B
| $19.7M | ﹤0.01% |
1,137,265
+668,799
| +143% | +$12.5M |
|
|
CWEN.A
2943
DELISTED
Clearway Energy Class A
CWEN.A
| $19.7M | ﹤0.01% |
625,958
+35,442
| +6% | +$1.11M |
|
2944
Albany International
AIN
$2.16B
| $19.6M | ﹤0.01% |
387,380
-394,456
| -50% | -$20.4M |
|
2945
VanEck Vietnam ETF
VNM
$479M
| $19.6M | ﹤0.01% |
1,027,395
+755,701
| +278% | +$13.7M |
|
|
WBTN
2946
WEBTOON Entertainment Inc
WBTN
$1.25B
| $19.6M | ﹤0.01% |
1,504,375
-224,954
| -13% | -$3.45M |
|
2947
VanEck Agribusiness ETF
MOO
$998M
| $19.6M | ﹤0.01% |
269,164
-22,222
| -8% | -$1.61M |
|
2948
Kodiak Sciences
KOD
$2.52B
| $19.6M | ﹤0.01% |
699,772
+52,185
| +8% | +$1.07M |
|
|
HQL
2949
abrdn Life Sciences Investors
HQL
$589M
| $19.5M | ﹤0.01% |
1,164,826
+294,168
| +34% | +$4.94M |
|
2950
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.3B
| $19.5M | ﹤0.01% |
835,545
-6,055
| -0.7% | -$142K |
|
Similar funds
Morgan Stanley's Q4 2025 Portfolio in Review
As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2025 filing shows 427 new, 3,948 increased, 2,961 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
- Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
- Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
- Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
- Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
- Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.
Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.